MKI67 and neoplasm: Following NET prescription, pCR seems a less achievable primary analytical endpoint when compared to NAC, building argument for inclusion of reduction of tumour cellularity, successful BCS, or molecular parameters, such as Ki-67 or Preoperative Endocrine Prognostic (PEPI) Indices to be incorporated into planning of prospective NET studies [50,51].